HYDERABAD: Covaxin, India’s first indigenous vaccine candidate for the Covid-19 vaccine, began phase III clinical trials on Monday in what is the country’s largest human trial of a vaccine for the dreaded coronavirus. Trials began in Hyderabad with the first doses of the candidate vaccine administered to volunteers at the …
Read More »